Yanwei Zhong
About
In The Last Decade
Yanwei Zhong
56 papers receiving 660 citations
Peers
Comparison fields: 5 of 61
- Epidemiology 520
- Hepatology 474
- Infectious Diseases 92
- Molecular Biology 87
- Pharmacology 44
Countries citing papers authored by Yanwei Zhong
This map shows the geographic impact of Yanwei Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanwei Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanwei Zhong more than expected).
Fields of papers citing papers by Yanwei Zhong
This network shows the impact of papers produced by Yanwei Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanwei Zhong. The network helps show where Yanwei Zhong may publish in the future.
Co-authorship network of co-authors of Yanwei Zhong
This figure shows the co-authorship network connecting the top 25 collaborators of Yanwei Zhong. A scholar is included among the top collaborators of Yanwei Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanwei Zhong. Yanwei Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 13 | |
| 3 | 3 | |
| 4 | 11 | |
| 5 | 19 | |
| 6 | Relationship between single nucleotide polymorphism of chemokine CXCL10 G-210A and the chronicity and severity of HBV infection | 1 |
| 7 | 10 | |
| 8 | 16 | |
| 9 | 20 | |
| 10 | 33 | |
| 11 | 76 | |
| 12 | 41 | |
| 13 | 3 | |
| 14 | 60 | |
| 15 | 6 | |
| 16 | Screening of augmenter of liver regeneration-binding proteins by yeast-two hybrid technique. | 5 |
| 17 | 6 | |
| 18 | 4 | |
| 19 | [The preparation of human single chain Fv antibody specifically against hepatitis C virus NS3 antigen and its application in immunohistochemistry]. | 1 |
| 20 | Expression of human single-chain variable fragment antibody against non-structural protein 3 of hepatitis C virus antigen in e.coli. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.